- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 13/00 - Drugs for disorders of the urinary system
Patent holdings for IPC class A61P 13/00
Total number of patents in this class: 942
10-year publication summary
|
37
|
43
|
58
|
65
|
82
|
61
|
71
|
40
|
38
|
14
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Bayer AG | 3433 |
23 |
| Allergan, Inc. | 2208 |
19 |
| Bayer Pharma AG | 1028 |
18 |
| F. Hoffmann-La Roche AG | 7839 |
16 |
| Astellas Pharma Inc. | 1030 |
15 |
| Takeda Pharmaceutical Company Limited | 2721 |
11 |
| Shionogi & Co., Ltd. | 863 |
11 |
| Boehringer Ingelheim International GmbH | 4510 |
9 |
| Santa Farma İlaç Sanayi̇ A.ş. | 58 |
9 |
| Novartis AG | 10345 |
7 |
| AstraZeneca AB | 2837 |
7 |
| Janssen Pharmaceutica N.V. | 3234 |
7 |
| sanofi-aventis | 328 |
7 |
| Janssen Pharmaceuticals, Inc. | 439 |
6 |
| Vertex Pharmaceuticals Incorporated | 1601 |
6 |
| Pfizer Inc. | 3371 |
5 |
| Merck Patent GmbH | 5663 |
5 |
| Angion Biomedica Corp. | 59 |
5 |
| Dainippon Sumitomo Pharma Co., Ltd. | 174 |
5 |
| Horizon Therapeutics, LLC | 25 |
5 |
| Other owners | 746 |